Maria C B Costa1, Willi McFarland2,3, Erin C Wilson2,3, Hui Xie2, Sean Arayasirikul2, Ferdinando D Moura1, Maria A S M Veras1. 1. Department of Collective Health, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil. 2. Center for Public Health Research, San Francisco Department of Public Health, San Francisco, California, USA. 3. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Abstract
Purpose: The purpose of this study was to determine the prevalence and correlates of nonprescription hormone use among Brazilian trans women. Methods: This study is a cross-sectional survey of trans women in São Paulo, Brazil, recruited by respondent-driven sampling in 2017-2019. Results: Of 790 trans women, 36.8% were taking nonprescribed hormones. Nonprescribed hormone use was higher with younger age, lower education, homelessness, and using estrogen plus progesterone. Lower use was associated with accessing health care and having trans-specific health needs met. Conclusion: Marginalized Brazilian trans women exhibit high use of nonprescription hormones, which may have health consequences and requires further examination and research.
Purpose: The purpose of this study was to determine the prevalence and correlates of nonprescription hormone use among Brazilian trans women. Methods: This study is a cross-sectional survey of trans women in São Paulo, Brazil, recruited by respondent-driven sampling in 2017-2019. Results: Of 790 trans women, 36.8% were taking nonprescribed hormones. Nonprescribed hormone use was higher with younger age, lower education, homelessness, and using estrogen plus progesterone. Lower use was associated with accessing health care and having trans-specific health needs met. Conclusion: Marginalized Brazilian trans women exhibit high use of nonprescription hormones, which may have health consequences and requires further examination and research.
Entities:
Keywords:
Brazil; health care access; hormones; nonprescription drugs; transgender persons
Authors: Martha Helena Teixeira de Souza; Paulo Malvasi; Marcos Claudio Signorelli; Pedro Paulo Gomes Pereira Journal: Cad Saude Publica Date: 2015-04 Impact factor: 1.632
Authors: Darios Getahun; Rebecca Nash; W Dana Flanders; Tisha C Baird; Tracy A Becerra-Culqui; Lee Cromwell; Enid Hunkeler; Timothy L Lash; Andrea Millman; Virginia P Quinn; Brandi Robinson; Douglas Roblin; Michael J Silverberg; Joshua Safer; Jennifer Slovis; Vin Tangpricha; Michael Goodman Journal: Ann Intern Med Date: 2018-07-10 Impact factor: 25.391
Authors: Angelo Brandelli Costa; Heitor Tome da Rosa Filho; Paola Fagundes Pase; Anna Martha Vaitses Fontanari; Ramiro Figueiredo Catelan; Andressa Mueller; Dhiordan Cardoso; Bianca Soll; Karine Schwarz; Maiko Abel Schneider; Daniel Augusto Mori Gagliotti; Alexandre Saadeh; Maria Inês Rodrigues Lobato; Henrique Caetano Nardi; Silvia Helena Koller Journal: J Immigr Minor Health Date: 2018-02
Authors: Wylie C Hembree; Peggy Cohen-Kettenis; Henriette A Delemarre-van de Waal; Louis J Gooren; Walter J Meyer; Norman P Spack; Vin Tangpricha; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2009-06-09 Impact factor: 5.958
Authors: Maria I Lobato; Bianca M Soll; Angelo Brandelli Costa; Alexandre Saadeh; Daniel A M Gagliotti; Ana Fresán; Geoffrey Reed; Rebeca Robles Journal: Braz J Psychiatry Date: 2019-03-07 Impact factor: 2.697